Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AGN [NYSE]
Allergan Inc.
IndexS&P 500 P/E42.60 EPS (ttm)4.37 Insider Own0.10% Shs Outstand297.18M Perf Week2.29%
Market Cap55.32B Forward P/E22.10 EPS next Y8.42 Insider Trans5.32% Shs Float296.61M Perf Month12.06%
Income1.32B PEG2.22 EPS next Q1.67 Inst Own93.70% Short Float1.31% Perf Quarter7.96%
Sales6.75B P/S8.19 EPS this Y17.60% Inst Trans0.05% Short Ratio1.68 Perf Half Y12.42%
Book/sh22.80 P/B8.16 EPS next Y37.90% ROA11.90% Target Price205.83 Perf Year106.02%
Cash/sh12.50 P/C14.89 EPS next 5Y19.15% ROE19.50% 52W Range88.23 - 192.98 Perf YTD67.71%
Dividend0.20 P/FCF38.70 EPS past 5Y17.90% ROI15.70% 52W High-3.53% Beta0.72
Dividend %0.11% Quick Ratio3.80 Sales past 5Y7.40% Gross Margin87.80% 52W Low110.99% ATR6.13
Employees11700 Current Ratio4.10 Sales Q/Q16.70% Oper. Margin30.70% RSI (14)61.14 Volatility4.06% 3.51%
OptionableYes Debt/Eq0.32 EPS Q/Q17.10% Profit Margin18.70% Rel Volume0.84 Prev Close179.25
ShortableYes LT Debt/Eq0.31 EarningsOct 27 BMO Payout4.60% Avg Volume2.31M Price186.16
Recom1.70 SMA203.32% SMA509.24% SMA20023.31% Volume1,931,417 Change3.85%
09-Oct-14Initiated Deutsche Bank Buy $215
01-Oct-14Upgrade Stifel Hold → Buy $200
22-Jul-14Upgrade UBS Neutral → Buy $180 → $200
28-Apr-14Downgrade Stifel Buy → Hold
22-Apr-14Downgrade Argus Buy → Hold
07-Mar-14Reiterated Barclays Equal Weight $95 → $130
07-Feb-14Reiterated Argus Buy $110 → $130
08-Jan-14Reiterated Argus Buy $110 → $125
07-Jan-14Initiated RBC Capital Mkts Outperform $131
20-Dec-13Reiterated UBS Buy $100 → $116
20-Dec-13Reiterated BMO Capital Markets Outperform $112 → $117
31-Oct-13Reiterated Argus Buy $118 → $110
25-Jun-13Reiterated Canaccord Genuity Hold $111 → $98
24-Jun-13Downgrade Deutsche Bank Buy → Hold
02-May-13Reiterated RBC Capital Mkts Outperform $123 → $119
06-Feb-13Reiterated Stifel Nicolaus Buy $110 → $118
06-Feb-13Reiterated Canaccord Genuity Hold $102 → $111
22-Jan-13Reiterated Canaccord Genuity Hold $101 → $102
19-Sep-12Initiated Canaccord Genuity Hold $101
30-Mar-12Reiterated RBC Capital Mkts Outperform $93 → $106
21-Oct-14 03:09PM  Einhorn: Selloff Created Buying Opportunities, Embrace Higher Interest at TheStreet
03:04PM  Allergan keeps a few secrets, court filing shows at MarketWatch
12:42PM  Meister wants Allergan to sell for highest price CNBC
12:29PM  Valeant, Ackman: Allergan Spread 'Misleading' Info in Takeover Fight at The Wall Street Journal
10:50AM  Trade-Ideas: Allergan (AGN) Is Today's Momo Momentum Stock at TheStreet
10:45AM  Allergan says it stands by statements on Valeant Reuters
09:31AM  Deals of the Day: Reebok Reaction, Banana Development, IPO Delay at The Wall Street Journal
20-Oct-14 11:42PM  Ackman, Valeant lawyers say Allergan CEO oversaw campaign to discredit Valeant Reuters
07:39PM  Valeant hints at higher bid for Allergan at Financial Times
06:47PM  Can Valeant's Strong Q3 Entice Allergan? at Investor's Business Daily
06:20PM  Paulson Said to Urge Shire-Allergan Merger as AbbVie Talks End at Bloomberg
05:14PM  Actavis Said to Compete With Sanofi for Omega Pharma Deal at Bloomberg
03:31PM  Paulsons Hedge Fund Urges Botox-Maker Allergan to Consider Buying Shire at New York Times
03:13PM  Allergan files rebuttal to Valeant earnings at MarketWatch
01:55PM  Top Allergan holder Paulson urges deal with Shire: sources Reuters
01:53PM  Top Allergan holder Paulson urges deal with Shire -sources Reuters
01:52PM  Paulson & Co. pushes for Allergan merger with Shire: report at MarketWatch
12:51PM  Paulson Urges Allergan/Shire Tie-up at The Wall Street Journal
12:50PM  Valeant says may raise Allergan bid; beats on profit Reuters
12:15PM  [video] Report: Paulson pushing Allergan-Shire merger at CNBC
11:45AM  Jim Cramer: Valeant Pharmaceuticals and Allergan Are Winners at TheStreet
10:48AM  [$$] Valeant Pushes Business Strength at The Wall Street Journal
09:33AM  Valeant may raise Allergan bid, says it won't walk away Reuters
06:01AM  ALLERGAN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
17-Oct-14 03:29PM  The top 10 best-performing CEOs at Fortune
09:42AM  [video] Faber Report: Allergan takeover battle at CNBC
16-Oct-14 12:37PM  Ackman: Allergan tried to manipulate Valeant stock CNBC
12:37PM  [video] Ackman: Allergan tried to manipulate Valeant stock at CNBC
12:08PM  Ackman: Lawyers have documents purported to show Allergan misled on Valeant Reuters
11:10AM  Will Actavis Win Competition For Allergan's Affection? Benzinga
01:22AM  AbbVie Board To Shareholders: Vote No On Shire Buy at Investor's Business Daily
15-Oct-14 08:00AM  Harvard Business Review Ranks David Pyott One of the Top 5 CEOs in the World Business Wire
14-Oct-14 10:27AM  J&J Beats Q3 Earnings on Strong Drug Sales, Ups View Zacks
06:34AM  Time to Focus on Allergan (AGN) for Strong Earnings Growth Potential Zacks
13-Oct-14 12:22PM  Ackman, others seek what Buffett has probably in vain Yahoo Finance
09:19AM  Bill Ackman's new fund falls 6% in public debut in Amsterdam at MarketWatch
06:43AM  [video] Bill Ackman: Venezuela Could Kill Herbalife's Earnings at Bloomberg
10-Oct-14 04:20PM  Allergan Raises Outlook amidst Valeant Takeover Attempts Zacks
10:31AM  [video] Most resilient stocks at CNBC
10:03AM  Exclusive: Top Actavis holder, Fidelity, adds Allergan holdings- sources Reuters
09-Oct-14 06:25PM  Cramer: Activists are picking on the wrong chiefs at CNBC
06:15PM  Cramer's note to activist investors CNBC
06:15PM  [video] Cramer's note to activist investors at CNBC
06:00PM  Cramer: We are in a treacherous market CNBC
05:27PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
04:16PM  Bears Regain Control As Stocks Suffer Sharp Losses at Investor's Business Daily
03:15PM  Stocks' Slide Picks Up Steam; Icahn Note Buoys Apple at Investor's Business Daily
02:38PM  Coverage initiated on Allergan by Deutsche Bank Briefing.com
12:08PM  [$$] Allergan Raises Earnings Outlook at The Wall Street Journal
11:56AM  Allergan Steeply Raises Guidance, Taunts Valeant at Investor's Business Daily
11:22AM  Allergan, embroiled in takeover battle, raises its profit forecast at Los Angeles Times
10:57AM  Allergan says 3rd qtr and 2014 profit to beat expectations Reuters
10:51AM  Takeover target Allergan raises guidance at Financial Times
09:50AM  UPDATE 1-Allergan raises outlook; says Valeant offer undervalues company Reuters
09:41AM  Allergan, Inc. Shares Get A Bump Following Update On Performance Outlook Benzinga
09:40AM  [video] Faber Report: Allergan updates guidance at CNBC
08:57AM  A call to short chip makers in the face of a triple-top market at MarketWatch
08:28AM  How Will Allergan (AGN) Stock React Today to This Analyst Initiation? at TheStreet
07:51AM  Allergan raises outlook; says Valeant offer undervalues company Reuters
07:02AM  Allergan Raises Profit Forecast as Valeant Pursues Bid at Bloomberg
06:52AM  ALLERGAN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
06:45AM  Allergan Provides Update on Earnings Per Share and Sales Expectations Business Wire
06:34AM  Allergan, Inc Up As Deutsche Bank Initiates Coverage With Buy Rating Benzinga
08-Oct-14 06:30PM  Actavis deal for Allergan would be huge bet on branded drugs Reuters
05:20PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
12:52PM  Dealpolitik: Allergan Battle May Showcase Unintended Consequences of Inversion Rules at The Wall Street Journal
09:53AM  Allergan & Valeant & Actavis & Salix: Can This Love Quadrilateral Work? at Barrons.com
09:46AM  Stock Market Today: Reserved Start for Wall Street With Eyes on Fed at TheStreet
09:05AM  Yum China sales not so yummy; Costco tops estimates; Symantec jumps on breakup talk Hot Stock Minute
09:01AM  Stock Futures Aim For A Bounce; Symantec Up On Split Reports at Investor's Business Daily
08:28AM  Symantec jumps on split talk; Costco up on earnings at MarketWatch
08:19AM  #PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street Benzinga
07:57AM  Investors look to Fed minutes; Yum's profits slammed; Twitter sues U.S. Hot Stock Minute
07:44AM  Morning Agenda: Another Twist in Allergan Battle at New York Times
06:48AM  October 8 Premarket Briefing: 10 Things You Should Know TheStreet
05:00AM  'Fast Money' Recap: What Should You Buy in a Declining Market? at TheStreet
04:50AM  Exclusive: Actavis plans new merger approach for Allergan - sources Reuters
02:31AM  [$$] Valeant, Pershing Square to Boost Allergan Bid at The Wall Street Journal
07-Oct-14 08:05PM  [$$] Valeant to Boost Allergan Bid at The Wall Street Journal
07:38PM  COLUMN-Allergan's latest tactic to fend off Pershing: Frankel Reuters
07:33PM  Salix, Actavis Among Big Cap Pharmas In Merger Mambo at Investor's Business Daily
07:10PM  Valeant and Pershing Square to Raise Offer for Botox Maker Allergan at New York Times
07:07PM  Valeant Said to Plan on Raising Allergan Bid Near December Vote at Bloomberg
06:33PM  Actavis Finds Rx To Grow On Busy Drugmaker M&A Scene at Investor's Business Daily
05:58PM  DJ: Valeant & Pershing to boost Allergan bid CNBC
05:48PM  Valeant to boost Allergan bid by $15 a share: report at MarketWatch
05:41PM  Stock Pops & Drops: Mobileye, General Motors & more CNBC
05:41PM  [video] Stock Pops & Drops: Mobileye, General Motors & more at CNBC
05:15PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
03:48PM  Salix: The Field of Potential Buyers is Vast, Analyst Says at The Wall Street Journal
03:05PM  Actavis plans new Allergan approach: Report CNBC
01:57PM  [video] Allergan Asks Judge to Block Ackman From Voting Stock at Meeting at TheStreet
01:27PM  Allergan Is Open to Alternatives That Aren't Valeant at Bloomberg
11:37AM  [$$] M&A Boom Gets a Twist: Predators Turn Prey at The Wall Street Journal
08:02AM  Video: GoPro Among Top 6 Stocks Beating The Market at Investor's Business Daily
04:11AM  Allergan Asks Judge to Block Ackman From Voting Stock at Meeting at Bloomberg
06-Oct-14 06:29PM  Today's Market Thorns, Roses and All Time Highs... Yahoo Finance Blogs
04-Oct-14 08:02AM  Medical Stocks End Week On High Note, Biotechs Lead at Investor's Business Daily
03-Oct-14 09:23PM  A Scramble to Acquire for Drug Companies at New York Times
06:22PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
Allergan, Inc. operates as a multi-specialty health care company primarily in the United States, Europe, Latin America, and the Asia Pacific. The company discovers, develops, and commercializes pharmaceutical, biological, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological, and other specialty markets. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment produces a range of pharmaceutical products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy, and retinal disease; Botox for certain therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth, and other prescription and physician-dispensed skin care products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery, as well as tissue expanders; and facial aesthetics products. The company also holds LiRIS Program, which is in Phase II trials for the treatment of interstitial cystitis/bladder pain syndrome. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, ambulatory surgery centers, government purchasing agencies, and medical practitioners. The company focuses on eye care professionals, neurologists, physiatrists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, urologists, urogynecologists, and general practitioners. It has collaboration agreements with Molecular Partners AG; Spectrum Pharmaceuticals, Inc.; and Serenity Pharmaceuticals, LLC. Allergan, Inc. was founded in 1948 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sherman Scott DExecutive Vice President, HRApr 22Option Exercise75.5810,000755,80018,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 22Sale163.0010,0001,630,0008,223Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Option Exercise73.044,500328,68012,723Apr 23 07:25 PM
Sherman Scott DExecutive Vice President, HRApr 21Sale139.854,500629,3258,223Apr 23 07:25 PM
LAVIGNE LOUIS J JRDirectorFeb 21Sale125.795,400679,2440Feb 24 07:59 PM
INGRAM DOUGLAS SPresidentFeb 21Sale125.701961,044Feb 25 05:49 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Option Exercise58.5523,0001,346,65029,401Feb 21 04:56 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Option Exercise40.1638,9001,562,22455,491Feb 21 04:59 PM
HUDSON DAWN EDirectorFeb 19Sale126.354,200530,68311,600Feb 21 05:14 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 19Sale126.3938,9004,916,49316,591Feb 21 04:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 19Sale126.6623,0002,913,1116,401Feb 21 04:56 PM
Sherman Scott DExecutive Vice President, HRFeb 18Option Exercise75.585,000377,90013,220Feb 19 02:44 PM
Sherman Scott DExecutive Vice President, HRFeb 18Sale125.745,000628,7008,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Option Exercise55.9884,0004,701,90085,058Feb 19 02:41 PM
Sherman Scott DExecutive Vice President, HRFeb 14Sale124.761708,220Feb 19 02:44 PM
INGRAM DOUGLAS SPresidentFeb 14Sale124.4084,00010,449,4321,058Feb 19 02:41 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Option Exercise36.15252,0009,109,800417,000Feb 13 05:49 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Option Exercise65.9223,8751,573,76930,754Feb 13 05:54 PM
BARLOW JAMES FSR. VP, Corp. Controller (PAO)Feb 12Sale123.5223,8752,949,0416,879Feb 13 05:54 PM
PYOTT DAVID E IChairman of the Board and CEOFeb 12Sale123.12252,00031,025,560165,000Feb 13 05:49 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Option Exercise55.9817,000951,57523,401Feb 13 05:56 PM
LAVIGNE LOUIS J JRDirectorFeb 11Option Exercise55.2054,6003,014,01924,123Feb 13 05:59 PM
LAVIGNE LOUIS J JRDirectorFeb 11Sale122.3954,6006,682,69612,723Feb 13 05:59 PM
Diradoorian Raymond HEVPGlobal Technical OperationsFeb 11Sale121.8217,0002,070,9576,401Feb 13 05:56 PM
Sherman Scott DExecutive Vice President, HRFeb 10Option Exercise75.585,000377,90013,325Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 10Sale120.005,000600,0008,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Option Exercise64.47105,5006,801,585122,371Feb 11 08:37 PM
Sherman Scott DExecutive Vice President, HRFeb 07Option Exercise73.044,500328,68012,825Feb 11 08:41 PM
Sherman Scott DExecutive Vice President, HRFeb 07Sale118.554,500533,4848,325Feb 11 08:41 PM
EDWARDS JEFFREY LEVP, Fin & Bus. Dev., CFOFeb 07Sale117.74105,50012,421,04316,871Feb 11 08:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Option Exercise55.9842,0002,350,95059,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 14Sale117.8042,0004,947,60017,327Jan 15 06:24 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Option Exercise55.9842,0002,350,95059,327Jan 10 06:37 PM
Whitcup Scott MExecutive VP, R&D, CSOJan 08Sale113.8042,0004,779,60017,327Jan 10 06:37 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Option Exercise53.7152,5002,819,77545,547Dec 30 05:18 PM
Gangolli Julian SCVP & Pres, North AmericaDec 27Sale110.0552,5005,777,5508,047Dec 30 05:18 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise36.1533,0001,192,95033,827Dec 20 07:41 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Option Exercise0.0033,000033,827Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Jan 06 06:27 PM
Whitcup Scott MExecutive VP, R&D, CSODec 20Sale108.8033,0003,590,40017,327Dec 20 07:41 PM
HUDSON DAWN EDirectorNov 27Sale97.463,000292,38215,800Dec 02 04:52 PM